FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 56 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $813,173 | +19.7% | 183,147 | -11.1% | 0.00% | – |
Q2 2023 | $679,625 | -75.3% | 205,947 | -78.7% | 0.00% | – |
Q1 2023 | $2,751,926 | -75.8% | 965,588 | -38.1% | 0.00% | – |
Q4 2022 | $11,362,828 | +93.6% | 1,560,828 | +115.1% | 0.00% | – |
Q3 2022 | $5,869,000 | +84.7% | 725,517 | +11.8% | 0.00% | – |
Q2 2022 | $3,178,000 | -80.1% | 648,666 | -4.0% | 0.00% | -100.0% |
Q1 2022 | $15,986,000 | +29.5% | 675,954 | -3.1% | 0.00% | 0.0% |
Q4 2021 | $12,346,000 | -3.2% | 697,911 | +54.3% | 0.00% | 0.0% |
Q3 2021 | $12,760,000 | +290.0% | 452,312 | +44.9% | 0.00% | – |
Q2 2021 | $3,272,000 | +9.1% | 312,225 | +22.7% | 0.00% | – |
Q1 2021 | $2,998,000 | +6.9% | 254,497 | +6.3% | 0.00% | – |
Q4 2020 | $2,804,000 | +66.7% | 239,449 | +12.9% | 0.00% | – |
Q3 2020 | $1,682,000 | -55.6% | 212,055 | +2.4% | 0.00% | – |
Q2 2020 | $3,788,000 | +63.3% | 207,098 | +6.6% | 0.00% | – |
Q1 2020 | $2,319,000 | +256.8% | 194,262 | +397.5% | 0.00% | – |
Q4 2019 | $650,000 | – | 39,049 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |